OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications
Kamil Siekacz, Anna Kumor‐Kisielewska, Joanna Miłkowska-Dymanowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4253-4253
Open Access | Times Cited: 14

Showing 14 citing articles:

The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 9

Mitochondrial fusion protein: a new therapeutic target for lung injury diseases
Guiyang Jia, Erhong Song, Qianxia Huang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access

Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long COVID
Tamara Cruz, Núria Albacar, Estíbaliz Ruiz‐Ortiz, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access

Gut Microbiota and Mitochondria: Health and Pathophysiological Aspects of Long COVID
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17198-17198
Open Access | Times Cited: 7

Mitochondria in COVID-19: from cellular and molecular perspective
Michał Rurek
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 2

The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19
Reyhaneh Niayesh‐Mehr, Mojtaba Kalantar, Giulio Bontempi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Novel biomarkers of mitochondrial dysfunction in Long COVID patients
Titanilla Szögi, Barbara N. Borsos, Dejana Masic, et al.
GeroScience (2024)
Open Access | Times Cited: 1

Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology
Zhenpeng Sun, Li Zhang, Ruihong Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Diferencia en las distintas funciones de las lipoproteínas de alta densidad en respuesta a la infección por SARS-CoV-2
Belén Davico, Maximiliano Martín, Ezequiel Lozano Chiappe, et al.
Revista Argentina de Cardiología (2024) Vol. 92, Iss. 1, pp. 126-132
Open Access

Precision disease management: prognostic biomarker for chronic lung damage in long COVID
Adrian Oo, Justin Jang Hann Chu
ERJ Open Research (2024) Vol. 10, Iss. 6, pp. 00647-2024
Open Access

Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Helena Borland Madsen, Jon Ambæk Durhuus, Ove Andersen, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access

Interferon gene expression declines over time post-COVID infection and in long COVID patients
Alberto Gómez‐Carballa, Stefania Pischedda, Jacobo Pardo‐Seco, et al.
Infectious Diseases (2024) Vol. 57, Iss. 1, pp. 35-48
Open Access

Can we predict lung sequelae in post-COVID-19 patients?
Dorina Esendağlı, E. Koç, N. Ercan, et al.
Turkish Journal of Clinics and Laboratory (2023) Vol. 14, Iss. 4, pp. 760-776
Open Access

Page 1

Scroll to top